Bellevue: Low valuations, looming deals – Why BB Biotech sees new cycle
In the latest 'Meet the Manager' video from Citywire, Dr Christian Koch explores how innovation, valuation and the firepower of big pharma could fuel a biotech recovery.14.07.2025 | 07:41 Uhr